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Background
Complex Regional Pain Syndrome (CRPS) is a rare pain
condition that causes severe pain in one or more limbs
and results in severe loss of function. The management of
this condition is difficult and requires a very intensive
approach. In-patient rehabilitation is able to provide the
intensity of physiotherapy that is required to effectively
manage this condition.
Materials and methods
A retrospective case note review was performed for 23
patients with a diagnosis of CRPS. All children were seen
at Great Ormond Street Hospital, which has an ambula-
tory rehabilitation unit able to provide an intensive pro-
gramme including twice daily physiotherapy, advice on
pacing and pain management over a 2–3 week period. The
main philosophy of the programme is that function is
regained before pain is reduced.
Results
See table 1. The mean age was 10.38 years and 72%
female. Presentation included symptoms of cold, mottled
skin (30%) skin allodynia (56%) and loss of function
(82%) predominantly in a lower limb (95%). 65% were
using walking aids. 80% were hypermobile and 100% had
a significant loss of muscle strength in specific lower limb
muscle groups, including hip abductors, hip extensors,
inner range quadriceps and plantar flexors. The therapy
included active muscle retraining to regain normal move-
ment, function and muscle strength in 100%, only 40%
also had a skin desensitisation programme. All children
improved in symptoms and function including school
attendance.
Conclusion
An intensive rehabilitation approach to the management
of children with CRPS is very effective in reducing pain
and restoring function.
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Table 1: 
Mean age of onset (years) 10.35
Percentage Female 72%
Mean time to treatment (years) 0.57
Mean time to diagnosis (years) 1.1
Mean time to treatment at GOSH (years) 1.5
Mean pain score before treatment (VAS) 76/100
Mean pain score after treatment (VAS) 19/100
Mean CHAQ score before treatment 1.625/3
Mean CHAQ score after treatment 0.5/3
Reduced school attendance before treatment 80% (more than 60% of school missed in 80%)
Reduced school attendance after treatment 40% (more than 60% of school missed in 7%)